VERNEJOUL; Fabienne

Patent Applications and Registrations

Patent applications and USPTO patent grants for VERNEJOUL; Fabienne.The latest application filed is for "cyclic dinucleotides for cytokine induction".

Company Profile

2.8.12

VERNEJOUL; Fabienne - TOULOUSE FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cyclic Dinucleotides For Cytokine Induction App 20220017561 - VERNEJOUL; Fabienne ; et al.	2022-01-20
Pro-cyclic Dinucleotides And Pro-cyclic Dinucleotide Conjugates For Cytokine Induction App 20210353760 - LIOUX; Thierry ; et al.	2021-11-18
Cyclic dinucleotides for cytokine induction Grant 11,053,272 - Vernejoul , et al. July 6, 2	2021-07-06
Cyclic Dinucleotides For Cytokine Induction App 20200255469 - Kind Code	2020-08-13
Cyclic dinucleotides for cytokine induction Grant 10,562,929 - Vernejoul , et al. Feb	2020-02-18
Cyclic Dinucleotides For Cytokine Induction App 20180354983 - VERNEJOUL; Fabienne ; et al.	2018-12-13
Cyclic dinucleotides for cytokine induction Grant 10,011,630 - Vernejoul , et al. July 3, 2	2018-07-03
Combined Use Of A Chemotherapeutic Agent And A Cyclic Dinucleotide For Cancer Treatment App 20170340658 - VERNEJOUL; Fabienne ; et al.	2017-11-30
Conjugated TLR7 and/or TLR8 and TLR2 agonists Grant 9,567,336 - Vernejoul , et al. February 14, 2	2017-02-14
Cyclic Dinucleotides For Cytokine Induction App 20160362441 - VERNEJOUL; Fabienne ; et al.	2016-12-15
Compositions of TLR7 and/or TLR8 agonists conjugated to lipids Grant 9,458,184 - Vernejoul , et al. October 4, 2	2016-10-04
Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy Grant 9,364,494 - Buscail , et al. June 14, 2	2016-06-14
Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists Grant 9,295,732 - Lioux , et al. March 29, 2	2016-03-29
Combination Products For Treating Cancer App 20150190480 - BUSCAIL; LOUIS ; et al.	2015-07-09
Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists App 20140242108 - LIOUX; Thierry ; et al.	2014-08-28
Conjugated Tlr7 And/or Tlr8 And Tlr2 Agonists App 20140141033 - VERNEJOUL; Fabienne ; et al.	2014-05-22
Novel Compositions Of Tlr7 And/or Tlr8 Agonists Conjugated To Lipids App 20130336996 - VERNEJOUL; Fabienne ; et al.	2013-12-19
Lyophilized Plasmid/dna Transfection Reagent Carrier Complex App 20110008894 - RAVET; Emmanuel ; et al.	2011-01-13
Combination Products For Treating Cancer App 20100222418 - Buscail; Louis ; et al.	2010-09-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.